China Pharma Holdings (CPHI) Reports Q3 Earnings of $0.08
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as higher yields and oil prices flag inflation risk
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts CPHI Hot Sheet
Price: $1.09 +28.24%
Financial Fact:
Bad debt expense (benefit): -69.9K
Today's EPS Names:
PKE, BYRN, HELE, More
Financial Fact:
Bad debt expense (benefit): -69.9K
Today's EPS Names:
PKE, BYRN, HELE, More
Join SI Premium – FREE
China Pharma Holdings (NYSE: CPHI) reported Q3 EPS of $0.08, versus $0.14 reported last year. Revenue for the quarter came in at $20.99 million, versus $18.68 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novagold Resources, Inc. (NG) Misses Q3 EPS by 2c
- ArcBest Corp (ARCB) PT Lowered to $168 at Stifel, Buy Rating Maintained on 'Sound Financial Footing'
- RB Global names new CFO, reshapes leadership, raises 2026 outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
